2023-08-182024-12-312024-12-31false15081923KNS BAGELS LTD2025-05-09falseiso4217:GBPxbrli:pure150819232023-08-18150819232024-12-31150819232023-08-182024-12-31150819232023-08-17150819232023-08-17150819232023-08-172023-08-1715081923bus:SmallEntities2023-08-182024-12-3115081923bus:AuditExempt-NoAccountantsReport2023-08-182024-12-3115081923bus:AbridgedAccounts2023-08-182024-12-3115081923bus:PrivateLimitedCompanyLtd2023-08-182024-12-3115081923core:WithinOneYear2024-12-3115081923core:AfterOneYear2024-12-3115081923core:WithinOneYear2023-08-1715081923core:AfterOneYear2023-08-1715081923core:ShareCapital2024-12-3115081923core:SharePremium2024-12-3115081923core:RevaluationReserve2024-12-3115081923core:OtherReservesSubtotal2024-12-3115081923core:RetainedEarningsAccumulatedLosses2024-12-3115081923core:ShareCapital2023-08-1715081923core:SharePremium2023-08-1715081923core:RevaluationReserve2023-08-1715081923core:OtherReservesSubtotal2023-08-1715081923core:RetainedEarningsAccumulatedLosses2023-08-1715081923core:LandBuildings2024-12-3115081923core:PlantMachinery2024-12-3115081923core:Vehicles2024-12-3115081923core:FurnitureFittings2024-12-3115081923core:OfficeEquipment2024-12-3115081923core:NetGoodwill2024-12-3115081923core:IntangibleAssetsOtherThanGoodwill2024-12-3115081923core:ListedExchangeTraded2024-12-3115081923core:UnlistedNon-exchangeTraded2024-12-3115081923core:LandBuildings2023-08-1715081923core:PlantMachinery2023-08-1715081923core:Vehicles2023-08-1715081923core:FurnitureFittings2023-08-1715081923core:OfficeEquipment2023-08-1715081923core:NetGoodwill2023-08-1715081923core:IntangibleAssetsOtherThanGoodwill2023-08-1715081923core:ListedExchangeTraded2023-08-1715081923core:UnlistedNon-exchangeTraded2023-08-1715081923core:LandBuildings2023-08-182024-12-3115081923core:PlantMachinery2023-08-182024-12-3115081923core:Vehicles2023-08-182024-12-3115081923core:FurnitureFittings2023-08-182024-12-3115081923core:OfficeEquipment2023-08-182024-12-3115081923core:NetGoodwill2023-08-182024-12-3115081923core:IntangibleAssetsOtherThanGoodwill2023-08-182024-12-3115081923core:ListedExchangeTraded2023-08-182024-12-3115081923core:UnlistedNon-exchangeTraded2023-08-182024-12-3115081923core:MoreThanFiveYears2023-08-182024-12-3115081923core:Non-currentFinancialInstruments2024-12-3115081923core:Non-currentFinancialInstruments2023-08-1715081923dpl:CostSales2023-08-182024-12-3115081923dpl:DistributionCosts2023-08-182024-12-3115081923core:LandBuildings2023-08-182024-12-3115081923core:PlantMachinery2023-08-182024-12-3115081923core:Vehicles2023-08-182024-12-3115081923core:FurnitureFittings2023-08-182024-12-3115081923core:OfficeEquipment2023-08-182024-12-3115081923dpl:AdministrativeExpenses2023-08-182024-12-3115081923core:NetGoodwill2023-08-182024-12-3115081923core:IntangibleAssetsOtherThanGoodwill2023-08-182024-12-3115081923dpl:GroupUndertakings2023-08-182024-12-3115081923dpl:ParticipatingInterests2023-08-182024-12-3115081923dpl:GroupUndertakingscore:ListedExchangeTraded2023-08-182024-12-3115081923core:ListedExchangeTraded2023-08-182024-12-3115081923dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-08-182024-12-3115081923core:UnlistedNon-exchangeTraded2023-08-182024-12-3115081923dpl:CostSales2023-08-172023-08-1715081923dpl:DistributionCosts2023-08-172023-08-1715081923core:LandBuildings2023-08-172023-08-1715081923core:PlantMachinery2023-08-172023-08-1715081923core:Vehicles2023-08-172023-08-1715081923core:FurnitureFittings2023-08-172023-08-1715081923core:OfficeEquipment2023-08-172023-08-1715081923dpl:AdministrativeExpenses2023-08-172023-08-1715081923core:NetGoodwill2023-08-172023-08-1715081923core:IntangibleAssetsOtherThanGoodwill2023-08-172023-08-1715081923dpl:GroupUndertakings2023-08-172023-08-1715081923dpl:ParticipatingInterests2023-08-172023-08-1715081923dpl:GroupUndertakingscore:ListedExchangeTraded2023-08-172023-08-1715081923core:ListedExchangeTraded2023-08-172023-08-1715081923dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-08-172023-08-1715081923core:UnlistedNon-exchangeTraded2023-08-172023-08-1715081923core:NetGoodwill2024-12-3115081923core:IntangibleAssetsOtherThanGoodwill2024-12-3115081923core:LandBuildings2024-12-3115081923core:PlantMachinery2024-12-3115081923core:Vehicles2024-12-3115081923core:FurnitureFittings2024-12-3115081923core:OfficeEquipment2024-12-3115081923core:AfterOneYear2024-12-3115081923core:WithinOneYear2024-12-3115081923core:ListedExchangeTraded2024-12-3115081923core:UnlistedNon-exchangeTraded2024-12-3115081923core:ShareCapital2024-12-3115081923core:SharePremium2024-12-3115081923core:RevaluationReserve2024-12-3115081923core:OtherReservesSubtotal2024-12-3115081923core:RetainedEarningsAccumulatedLosses2024-12-3115081923core:NetGoodwill2023-08-1715081923core:IntangibleAssetsOtherThanGoodwill2023-08-1715081923core:LandBuildings2023-08-1715081923core:PlantMachinery2023-08-1715081923core:Vehicles2023-08-1715081923core:FurnitureFittings2023-08-1715081923core:OfficeEquipment2023-08-1715081923core:AfterOneYear2023-08-1715081923core:WithinOneYear2023-08-1715081923core:ListedExchangeTraded2023-08-1715081923core:UnlistedNon-exchangeTraded2023-08-1715081923core:ShareCapital2023-08-1715081923core:SharePremium2023-08-1715081923core:RevaluationReserve2023-08-1715081923core:OtherReservesSubtotal2023-08-1715081923core:RetainedEarningsAccumulatedLosses2023-08-1715081923core:NetGoodwill2023-08-1715081923core:IntangibleAssetsOtherThanGoodwill2023-08-1715081923core:LandBuildings2023-08-1715081923core:PlantMachinery2023-08-1715081923core:Vehicles2023-08-1715081923core:FurnitureFittings2023-08-1715081923core:OfficeEquipment2023-08-1715081923core:AfterOneYear2023-08-1715081923core:WithinOneYear2023-08-1715081923core:ListedExchangeTraded2023-08-1715081923core:UnlistedNon-exchangeTraded2023-08-1715081923core:ShareCapital2023-08-1715081923core:SharePremium2023-08-1715081923core:RevaluationReserve2023-08-1715081923core:OtherReservesSubtotal2023-08-1715081923core:RetainedEarningsAccumulatedLosses2023-08-1715081923core:AfterOneYear2023-08-182024-12-3115081923core:WithinOneYear2023-08-182024-12-3115081923core:Non-currentFinancialInstrumentscore:CostValuation2023-08-182024-12-3115081923core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-08-182024-12-3115081923core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-08-182024-12-3115081923core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-08-182024-12-3115081923core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-08-182024-12-3115081923core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-08-182024-12-3115081923core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-08-182024-12-3115081923core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-08-182024-12-3115081923core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-08-182024-12-3115081923core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3115081923core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3115081923core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3115081923core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3115081923core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3115081923core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3115081923core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3115081923core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3115081923core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3115081923core:Non-currentFinancialInstrumentscore:CostValuation2023-08-1715081923core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-08-1715081923core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-08-1715081923core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-08-1715081923core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-08-1715081923core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-08-1715081923core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-08-1715081923core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-08-1715081923core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-08-1715081923bus:Director12023-08-182024-12-31

KNS BAGELS LTD

Registered Number
15081923
(England and Wales)

Unaudited Financial Statements for the Period ended
31 December 2024

KNS BAGELS LTD
Company Information
for the period from 18 August 2023 to 31 December 2024

Director

Mr K Abdi

Registered Address

First Street Bagels
1 Cakebread Street
Manchester
M12 6HF

Registered Number

15081923 (England and Wales)
KNS BAGELS LTD
Balance Sheet as at
31 December 2024

Notes

2024

£

£

Fixed assets
Tangible assets312,075
12,075
Current assets
Debtors4,330
Cash at bank and on hand550
4,880
Creditors amounts falling due within one year(44,788)
Net current assets (liabilities)(39,908)
Total assets less current liabilities(27,833)
Provisions for liabilities(2,294)
Net assets(30,127)
Capital and reserves
Called up share capital100
Profit and loss account(30,227)
Shareholders' funds(30,127)
The financial statements were approved and authorised for issue by the Director on 9 May 2025, and are signed on its behalf by:
Mr K Abdi
Director
Registered Company No. 15081923
KNS BAGELS LTD
Notes to the Financial Statements
for the period ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Revenue from sale of goods
Turnover in respect of the sale of goods is recognised on despatch of the goods, which is the point at which the company transfers the significant risks and rewards of ownership of the goods to the customer. The company retains legal title of the goods until the customer pays, but this does not constitute a retention of the significant risks and rewards of ownership. The total turnover of the company for the year has been derived from its principal activity wholly undertaken within the United Kingdom.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost less accumulated depreciation and accumulated impairment losses. Cost includes costs which are directly attributable in bringing the asset to its location and condition so that it is capable of operating in the manner intended by management. Residual values used in the calculation of depreciable amount are the expected amounts which would currently be obtained from disposal of assets, after deducting the estimated costs of disposal, if the assets were already of the age and in the condition expected at the end of their useful lives. Profits and losses on the disposal of fixed assets are included in the calculation of profit for the period. The directors assess the company's tangible assets for evidence of impairment at each reporting date. Where there are indicators of impairment, the directors calculate recoverable amount of the asset(s) and compare this with the carrying amount. If recoverable amount is lower than carrying amount, the asset is written down to recoverable amount by way of an impairment loss which is recognised in profit or loss for the period. Impairment losses are reversed when there is evidence that the reasons giving rise to the original impairment have ceased to apply. Impairment losses are reversed through profit and loss but only to the extent that the reversal does not increase the carrying amount of the asset to the amount which would have been stated, net of depreciation, had no impairment loss been recognised.

Straight line (years)
Fixtures and fittings5
Financial instruments
A financial asset or financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit or loss. All other investments are subsequently measured at cost less impairment. Debtors and creditors which fall due within one year are recorded in the financial statements at transaction price and subsequently measured at amortised cost. If the effects of the time value of money are immaterial, they are measured at cost (less impairment for trade debtors). Debtors are reviewed for impairment at each reporting date and any impairments are recorded in profit or loss and shown within administrative expenses when there is objective evidence that a debtor is impaired. Objective evidence that a debtor is impaired arises when the customer is unable to settle amounts owing to the company or the customer becomes bankrupt. Debtors do not carry interest and are stated at their nominal value. Trade creditors are not interest-bearing and are stated at their nominal value. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset which exceeds what the carrying amount would have been had the impairment loss not previously been recognised.
2.Average number of employees

2024
Average number of employees during the year4
3.Tangible fixed assets

Total

£
Cost or valuation
Additions14,000
At 31 December 2414,000
Depreciation and impairment
Charge for year1,925
At 31 December 241,925
Net book value
At 31 December 2412,075
At 17 August 23-